Boston, MA -- (SBWIRE) -- 01/08/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Vapor Corp.,(OTCMKTS:VPCOD), RXi Pharmaceuticals Corp(OTCMKTS:RXII), Generex Biotechnology Corporation(OTCMKTS:GNBT), TITAN MEDICAL INC(OTCMKTS:TITXF)
Vapor Corp.,(OTCMKTS:VPCOD) opened its shares at the price of $8.00 for the day. Its closing price was $8.55 after gaining +8.23% for the day. The company traded with the total volume of 70,995.00 shares, while its average trading volume remained 179,537.00 shares. The beta of VPCOD stands at 9.34. Vapor Corp. designs, markets, and distributes electronic cigarettes and accessories primarily in the United States and Canada.
For How Long VPCOD will Fight for Profitability? Read This Trend Analysis report
RXi Pharmaceuticals Corp(OTCMKTS:RXII) percentage change surged +8.12% to close at $3.46 with the total traded volume of 223,415.00 shares, and average volume of 80,873.00. The 52 week range of the stock remained $2.10 - $10.74, while its day lowest price was $3.18 and it hit its day highest price at $3.54. RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNAi platform.
For How Long RXII’s Gloss will Attract Investors ? Find out via this report
Generex Biotechnology Corporation(OTCMKTS:GNBT) started its trading session with the price of $0.04 and closed at $0.0410 by scoring +7.33%. GNBT’s stocks traded with total volume of 11.76 million shares, while the average trading volume remained 2.32 million shares. The beta of GNBT stands at 2.12. Day range of the stock was $0.04 -$0.04. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
TITAN MEDICAL INC(OTCMKTS:TITXF) ended its day with the gain of +7.10% and closed at the price of $1.01 after opening at $0.94. Stock traded during its last trading session with the total volume of 196,508.00 shares, as compared to its average volume of 240,279.00 shares. Titan Medical Inc., a development stage company, engages in the design and development of Amadeus robotic surgical system for application in minimally invasive surgery (MIS).
Why Should Investors Buy TITXF After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)